VEGFR Tyrosine Kinase Inhibitor II

• CAT Number: I011835
• CAS Number: 269390-69-4
• Molecular Formula: C19H16ClN3O
• Molecular Weight: 337.80
• Purity: ≥95%
• Synonyms: N-(4-chlorophenyl)-2-[(4-pyridinylmethyl)amino]-benzamide
• Target: JAK/STAT Signaling
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: N-(4-chlorophenyl)-2-(pyridin-4-ylmethylamino)benzamide
• InChI: InChI=1S/C19H16ClN3O/c20-15-5-7-16(8-6-15)23-19(24)17-3-1-2-4-18(17)22-13-14-9-11-21-12-10-14/h1-12,22H,13H2,(H,23,24)
• InChIKey: GGPZCOONYBPZEW-UHFFFAOYSA-N
• SMILES: C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)Cl)NCC3=CC=NC=C3

VEGFR Tyrosine Kinase Inhibitor II(Cat No.:I011835) is a small molecule inhibitor that targets the tyrosine kinase activity of vascular endothelial growth factor receptors (VEGFRs), which play a key role in angiogenesis and tumor growth. By inhibiting the tyrosine kinase activity of VEGFRs, VEGFR Tyrosine Kinase Inhibitor II can block the signaling pathways involved in angiogenesis and tumor growth, which has potential therapeutic applications in the treatment of cancer and other diseases. VEGFR Tyrosine Kinase Inhibitor II has been widely used as a research tool to study VEGFR signaling pathways and for the development of novel anticancer therapies.